PacBio management to participate in investor conferences.
PorAinvest
miércoles, 6 de agosto de 2025, 9:07 am ET1 min de lectura
MS--
PacBio, headquartered in Menlo Park, California, specializes in designing, developing, and manufacturing advanced sequencing solutions to help scientists and clinical researchers resolve genetically complex problems [3]. The company's products and technologies, including HiFi long-read sequencing, address a broad range of research applications such as human germline sequencing, plant and animal sciences, infectious disease and microbiology, oncology, and other emerging applications [3]. PacBio's solutions are provided for Research Use Only and are not intended for use in diagnostic procedures [3].
The Canaccord Genuity 45th Annual Growth Conference will take place on Tuesday, August 12, 2025, at 2:30 PM ET in Boston, Massachusetts. The Morgan Stanley 23rd Annual Global Healthcare Conference will be held on Wednesday, September 10, 2025, at 12:20 PM ET in New York, New York [1]. Investors can access the live webcasts of these events through PacBio's investor relations website, with replays available for at least 30 days following each event [1].
References:
1. [1] https://www.stocktitan.net/news/PACB/pac-bio-to-present-at-upcoming-investor-2horjqbhc0sh.html
2. [2] https://www.globenewswire.com/news-release/2025/08/06/3128361/16261/en/PacBio-to-Present-at-Upcoming-Investor-Conferences.html
3. [3] https://www.pacb.com
PACB--
PacBio, a developer of high-quality sequencing solutions, announced that management will participate in upcoming investor conferences. The events include the Canaccord Genuity 45th Annual Growth Conference on August 12, 2025, and the Morgan Stanley 23rd Annual Global Healthcare Conference on September 10, 2025. Live webcasts of the events can be accessed on the company's investors page. A replay will be available for at least 30 days following the event.
PacBio (NASDAQ: PACB), a leading developer of high-quality sequencing solutions, has announced its participation in two upcoming investor conferences. The events include the Canaccord Genuity 45th Annual Growth Conference on August 12, 2025, and the Morgan Stanley 23rd Annual Global Healthcare Conference on September 10, 2025 [1]. Management will present at both conferences, with live webcasts available for investors to access on the company's investors page. Replays of the webcasts will be available for at least 30 days following each event [2].PacBio, headquartered in Menlo Park, California, specializes in designing, developing, and manufacturing advanced sequencing solutions to help scientists and clinical researchers resolve genetically complex problems [3]. The company's products and technologies, including HiFi long-read sequencing, address a broad range of research applications such as human germline sequencing, plant and animal sciences, infectious disease and microbiology, oncology, and other emerging applications [3]. PacBio's solutions are provided for Research Use Only and are not intended for use in diagnostic procedures [3].
The Canaccord Genuity 45th Annual Growth Conference will take place on Tuesday, August 12, 2025, at 2:30 PM ET in Boston, Massachusetts. The Morgan Stanley 23rd Annual Global Healthcare Conference will be held on Wednesday, September 10, 2025, at 12:20 PM ET in New York, New York [1]. Investors can access the live webcasts of these events through PacBio's investor relations website, with replays available for at least 30 days following each event [1].
References:
1. [1] https://www.stocktitan.net/news/PACB/pac-bio-to-present-at-upcoming-investor-2horjqbhc0sh.html
2. [2] https://www.globenewswire.com/news-release/2025/08/06/3128361/16261/en/PacBio-to-Present-at-Upcoming-Investor-Conferences.html
3. [3] https://www.pacb.com
Divulgación editorial y transparencia de la IA: Ainvest News utiliza tecnología avanzada de Modelos de Lenguaje Largo (LLM) para sintetizar y analizar datos de mercado en tiempo real. Para garantizar los más altos estándares de integridad, cada artículo se somete a un riguroso proceso de verificación con participación humana.
Mientras la IA asiste en el procesamiento de datos y la redacción inicial, un miembro editorial profesional de Ainvest revisa, verifica y aprueba de forma independiente todo el contenido para garantizar su precisión y cumplimiento con los estándares editoriales de Ainvest Fintech Inc. Esta supervisión humana está diseñada para mitigar las alucinaciones de la IA y garantizar el contexto financiero.
Advertencia sobre inversiones: Este contenido se proporciona únicamente con fines informativos y no constituye asesoramiento profesional de inversión, legal o financiero. Los mercados conllevan riesgos inherentes. Se recomienda a los usuarios que realicen una investigación independiente o consulten a un asesor financiero certificado antes de tomar cualquier decisión. Ainvest Fintech Inc. se exime de toda responsabilidad por las acciones tomadas con base en esta información. ¿Encontró un error? Reportar un problema

Comentarios
Aún no hay comentarios